SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+0.25%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$520M
AUM Growth
+$520M
(+0.68%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$9.6M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$5.08M |
| 3 |
TSVT
2seventy bio
TSVT
|
$4.86M |
| 4 |
Treace Medical Concepts
TMCI
|
$4.7M |
| 5 |
Vera Therapeutics
VERA
|
$4.66M |
Top Sells
| 1 |
Exelixis
EXEL
|
$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$6.05M |
| 3 |
iRhythm Technologies
IRTC
|
$4.59M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.22M |
| 5 |
Arrowhead Research
ARWR
|
$3.87M |
Sector Composition
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Evolent Health
EVH
$1.12B
| $15.9M | 3.06% | 491,142 -94,500 | -16% | -$3.07M |
|
|
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.2M | 2.74% | 949,194 -403,350 | -30% | -$6.05M |
|
|
SWAV
3
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $13.6M | 2.61% | 62,550 +23,450 | +60% | +$5.08M |
|
4
UnitedHealth
UNH
$281B
| $12.3M | 2.37% | 26,075 +800 | +3% | +$378K |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.1M | 2.33% | 124,430 -14,350 | -10% | -$1.4M |
|
|
RXDX
6
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $11.6M | 2.23% | 108,090 -4,120 | -4% | -$442K |
|
7
Apellis Pharmaceuticals
APLS
$3.48B
| $11.4M | 2.19% | 172,490 +20,150 | +13% | +$1.33M |
|
8
PTC Therapeutics
PTCT
$3.92B
| $11M | 2.11% | 226,566 -925 | -0.4% | -$44.8K |
|
9
Icon
ICLR
$13.8B
| $10.8M | 2.07% | 50,538 -6,112 | -11% | -$1.31M |
|
10
HealthEquity
HQY
$7.72B
| $10.8M | 2.07% | 183,375 -60,400 | -25% | -$3.55M |
|
11
Lantheus
LNTH
$3.73B
| $9.72M | 1.87% | 117,687 -15,000 | -11% | -$1.24M |
|
12
Johnson & Johnson
JNJ
$427B
| $9.63M | 1.85% | 62,100 | – | – |
|
|
13
Mineralys Therapeutics
MLYS
$1.03B
| $9.6M | 1.85% | +613,233 | New | +$9.6M |
|
14
Option Care Health
OPCH
$4.65B
| $9.48M | 1.82% | 298,500 +25,000 | +9% | +$794K |
|
|
NARI
15
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $9.45M | 1.82% | 153,043 -27,700 | -15% | -$1.71M |
|
|
16
Treace Medical Concepts
TMCI
$464M
| $9.23M | 1.77% | 366,443 +186,519 | +104% | +$4.7M |
|
17
Insmed
INSM
$28.8B
| $8.8M | 1.69% | 516,092 | – | – |
|
18
Eli Lilly
LLY
$657B
| $8.16M | 1.57% | 23,765 +5,350 | +29% | +$1.84M |
|
|
AGTI
19
DELISTED
Agiliti, Inc.
AGTI
| $8.15M | 1.57% | 510,222 +12,000 | +2% | +$192K |
|
20
Travere Therapeutics
TVTX
$1.56B
| $8.07M | 1.55% | 358,613 +66,293 | +23% | +$1.49M |
|
21
RadNet
RDNT
$5.52B
| $7.83M | 1.51% | 312,933 +16,000 | +5% | +$400K |
|
22
Privia Health
PRVA
$2.83B
| $7.74M | 1.49% | 280,312 -41,000 | -13% | -$1.13M |
|
|
23
iRhythm Technologies
IRTC
$5.46B
| $7.33M | 1.41% | 59,136 -37,000 | -38% | -$4.59M |
|
24
Amylyx Pharmaceuticals
AMLX
$836M
| $7.11M | 1.37% | 242,400 +84,450 | +53% | +$2.48M |
|
25
AtriCure
ATRC
$1.84B
| $6.61M | 1.27% | 159,532 -67,000 | -30% | -$2.78M |
|